Despite fears of artificial intelligence (AI) disruption, this company is still seeing strong revenue and earnings growth.
Iopofosine I-131 achieved an overall response rate of 83.6% and a major response rate of 61.8% in patients with relapsed or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results